Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ...

The implantable lens maker said it would remain a stand-alone company after its shareholders turned down Alcon’s $1.6 billion ...

Staar Surgical announced that preliminary estimates suggest that it failed to receive stockholder approval for its planned ...

STAAR Surgical said shareholders rejected its merger with Alcon, ending the $1.6 billion deal. The eye care company will ...

Please provide your email address to receive an email when new articles are posted on . Alcon announced plans to launch its Total30 for Astigmatism, a reusable, water-gradient contact lens, in the U.S ...

“Alcon is proud to be the title sponsor of SECO 2020 and welcomes the opportunity to connect with Eye Care Professionals (ECPs) while providing hands-on access to our latest, innovative eye care ...

GENEVA--(BUSINESS WIRE)--Alcon, the global leader in eye care, today announced plans to launch the newest addition to its robust contact lens portfolio – PRECISION1 ® daily disposable, silicone ...

BASEL, Switzerland, January 26, 2017 - Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof ® IQ PanOptix ® Toric presbyopia- and astigmatism-correcting ...

Most professionals experience their eureka moment sometime during the early years of their career—when a trusted mentor activates in them an interest or enthusiasm, say, or a project proves unusually ...

Novartis' ($NVS) Alcon received FDA approval for its implantable AcrySof IQ ReSTOR +2.5 Diopter intraocular lens (IOL), enabling vision correction at all distances in ...